Cargando…

E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia

T Lymphocyte Acute Lymphoblastic Leukemia (ALL) is an aggressive disease arising from transformation of T lymphocytes during their development. The mutation spectrum of T-ALL has revealed critical regulators of the growth and differentiation of normal and leukemic T lymphocytes. Approximately, 60% o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parriott, Geoffrey, Kee, Barbara L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065262/ https://www.ncbi.nlm.nih.gov/pubmed/35514954 http://dx.doi.org/10.3389/fimmu.2022.885144

Ejemplares similares

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a(-/-) T Acute Lymphoblastic Leukemia
por: Carr, Tiffany, et al.
Publicado: (2022)

Notch-Signaling Deregulation Induces Myeloid-Derived Suppressor Cells in T-Cell Acute Lymphoblastic Leukemia
por: Grazioli, Paola, et al.
Publicado: (2022)

Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia
por: Dhanyamraju, Pavan Kumar, et al.
Publicado: (2020)

Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
por: Jiménez-Morales, Silvia, et al.
Publicado: (2021)

Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells
por: Rodriguez, Anthony B., et al.
Publicado: (2022)

Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia
por: Pankaew, Saran, et al.
Publicado: (2022)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
por: Cools, Jan
Publicado: (2018)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
por: Tomuleasa, Ciprian, et al.
Publicado: (2018)

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
por: Khan, Maliha, et al.
Publicado: (2018)

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
por: Kordaß, Theresa, et al.
Publicado: (2018)

Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience
por: Duminuco, Andrea, et al.
Publicado: (2023)

T Cell Subsets During Early Life and Their Implication in the Treatment of Childhood Acute Lymphoblastic Leukemia
por: Saghafian-Hedengren, Shanie, et al.
Publicado: (2021)

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments
por: Xu, Xinjie, et al.
Publicado: (2021)

Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia
por: Liang, Haoyue, et al.
Publicado: (2023)

Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations
por: Rubinstein, Jeremy D., et al.
Publicado: (2023)

Serum heat shock protein 90 as a future predictive biomarker in childhood acute lymphoblastic leukemia
por: Pawlik-Gwozdecka, Dorota, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
por: Driouk, Lina, et al.
Publicado: (2020)

Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia
por: Hodroj, Mohammad Hassan, et al.
Publicado: (2023)

Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
por: Wei, Zhenyu, et al.
Publicado: (2023)

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia
por: Bensberg, Maike, et al.
Publicado: (2021)

Dicer Gene Expression as a Prognostic Factor in Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia in Fars Province
por: Farzaneh, Mohamad Reza, et al.
Publicado: (2016)

A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia
por: Robles-Valero, Javier, et al.
Publicado: (2017)

Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia
por: Veiga, Diogo F. T., et al.
Publicado: (2022)

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
por: Baumann, Niklas, et al.
Publicado: (2022)

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia
por: Zhang, Yinqiang, et al.
Publicado: (2022)

NF-κB1 Regulates Immune Environment and Outcome of Notch-Dependent T-Cell Acute Lymphoblastic Leukemia
por: Grazioli, Paola, et al.
Publicado: (2020)

Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction
por: Hong, Ruimin, et al.
Publicado: (2021)

The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia
por: Jackson, Thomas R., et al.
Publicado: (2021)

Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with Staphylococus Aureus enterotoxin-superantigen
por: Duarte, Alejandra, et al.
Publicado: (2023)

NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
por: Ibáñez-Navarro, Marta, et al.
Publicado: (2023)

NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia
por: Catherinet, Claire, et al.
Publicado: (2021)

Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances
por: Liu, Jile, et al.
Publicado: (2023)

Rapid transformation of chronic lymphocytic leukemia to acute lymphoblastic leukemia: A rare case report
por: Kaur, Manmeet, et al.
Publicado: (2016)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
por: Xu, Xinjie, et al.
Publicado: (2019)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration
por: Cao, Han-Yu, et al.
Publicado: (2023)

Transcriptional dysregulation of the multifunctional zinc finger factor 423 in acute lymphoblastic leukemia of childhood
por: Harder, Lena, et al.
Publicado: (2014)

JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
por: Mansour, Marc R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g7hd4hpo9tjkq475kpk6bt4gha